Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
John Sheppard, Mark Bergmann, Barry A Schechter, Jodi Luchs, Abayomi Ogundele & Paul Karpecki. (2021) Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca. Clinical Ophthalmology 15, pages 129-140.
Read now
Read now
Lauren Mason, Saad Jafri, Isabelle Dortonne & John D Sheppard$suffix/text()$suffix/text(). (2021) Emerging therapies for dry eye disease. Expert Opinion on Emerging Drugs 26:4, pages 401-413.
Read now
Read now
Bridgitte Shen Lee, Alan G Kabat, Jason Bacharach, Paul Karpecki & Jodi Luchs. (2020) Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current Therapies. Clinical Ophthalmology 14, pages 119-126.
Read now
Read now
Rodrigo Carlos de Oliveira & Steven E Wilson. (2019) Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease. Clinical Ophthalmology 13, pages 1115-1122.
Read now
Read now
Kevin Chen, Maria Carolina Ibañez Bruron, Sebastian Mondaca, Gonzalo Pizarro, Paulina Liberman & Meghan K. Berkenstock. Quantitative Ocular Surface Changes in Patients Undergoing Immune Checkpoint Inhibitor Therapy. Ocular Immunology and Inflammation 0:0, pages 1-4.
Read now
Read now
Articles from other publishers (10)
Elisabeth M Messmer, Sajjad Ahmad, José M Benitez del Castillo, Ewa Mrukwa-Kominek, Maurizio Rolando, Oksana Vitovska & Christophe Baudouin. (2022) Management of inflammation in dry eye disease: Recommendations from a European panel of experts. European Journal of Ophthalmology 33:3, pages 1294-1307.
Crossref
Crossref
Yi-Chen Sun, Li-Li Wu, Yu-An Chang, Tzu-Yun Li, Yang Lin, Fung-Rong Hu, Wei-Bor Tsai & Kai-Feng Hung. (2022) Zwitterionic poly(carboxybetaine methacrylate) (polyCBMA) decreases desiccating damage to corneal epithelial cells. Colloid and Interface Science Communications 50, pages 100648.
Crossref
Crossref
David Cui, Gavin Li & Esen K. Akpek. (2021) Autologous serum eye drops for ocular surface disorders. Current Opinion in Allergy & Clinical Immunology 21:5, pages 493-499.
Crossref
Crossref
Rujun Jin, Ying Li, Lan Li, Jonghwa Kim, Hyeon Yoon & Kyung Yoon. (2021) Comparative analysis of 0.1% cyclosporin A cationic emulsion and 0.05% cyclosporin A emulsion in murine dry eye cases with different severities. Experimental and Therapeutic Medicine 22:6.
Crossref
Crossref
Xiaotong Ren, Yilin Chou, Xiaodan Jiang, Ran Hao, Yuexin Wang, Yanyan Chen & Xuemin Li. (2020) Effects of Oral Vitamin B1 and Mecobalamin on Dry Eye Disease. Journal of Ophthalmology 2020, pages 1-9.
Crossref
Crossref
Roseline Mazet, Josias B. G. Yaméogo, Denis Wouessidjewe, Luc Choisnard & Annabelle Gèze. (2020) Recent Advances in the Design of Topical Ophthalmic Delivery Systems in the Treatment of Ocular Surface Inflammation and Their Biopharmaceutical Evaluation. Pharmaceutics 12:6, pages 570.
Crossref
Crossref
Preeya K. Gupta, Penny Asbell & John Sheppard. (2020) Current and Future Pharmacological Therapies for the Management of Dry Eye. Eye & Contact Lens: Science & Clinical Practice 46:2, pages S64-S69.
Crossref
Crossref
Charles W. McMonnies. (2019) Dry eye disease immune responses and topical therapy. Eye and Vision 6:1.
Crossref
Crossref
Erin C. O’Neil, Matthew Henderson, Mina Massaro-Giordano & Vatinee Y. Bunya. (2019) Advances in dry eye disease treatment. Current Opinion in Ophthalmology 30:3, pages 166-178.
Crossref
Crossref
Barbara SassenBarbara Sassen. 2019. Preventie door paramedici. Preventie door paramedici
147
261
.